Blood article by MD Anderson researchers looks back at 107 MF patients who discontinued Jakafi

MPN News | March 22, 2018

Authors describe epigenetic mutations in some patients and suggest follow up research is needed

Read More

CR&T Shares videos from their 8th International MPN conference

MPN News | March 6, 2018

Watch video updates from MPN experts

Read More

CTI Biopharma expands it's clinical Trial

MPN News | March 1, 2018

CTI Biopharma is recruiting patients for the PAC203 study, a randomized phase 2 trial evaluating different doses of pacritinb in myelofibrosis patients. Previously, patients had to have a platelet count less than 100,000.

Read More

Recognizing some of the women in the MPN community

MPN News | March 6, 2018

March 8th is International Women's Day

Read More
MPN News | February 28, 2018

“Beyond Blue,” a short documentary by an award‐winning filmmaker, debuts to raise awareness of MPNs

Read More

Constellation Pharmaceuticals announced a Phase 2 study of CPI-0610 in patients with myelofibrosis.

MPN News | March 7, 2018

Constellation Pharmaceuticals announced a Phase 2 study of CPI-0610 alone or in combination with ruxolitinib in patients with myelofibrosis.

Read More

Asana BioSciences Announces a Phase II trial in patients with MF

MPN News | February 14, 2018

Asana BioSciences announces a Phase II study in patients with myelofibrosis is in progress in the US.

Read More

Read about the life of the Founder of MPNRF

MPN News | January 12, 2018

Obituary for Robert Rosen, Founder of the MPN Research Foundation

Read More

Celgene buys maker of Fedratinib

MPN News | January 9, 2018

Fedratinib may be approved for patients resistant to or intolerant of Jakafi

Read More

Two MPN experts discuss ASH 2017

MPN News | December 21, 2017

Return of old drugs, update to prognostic scoring system and more

Read More

Video updates from ASH 2017

MPN News | December 19, 2017

Four experts weigh in on the MPN updates

Read More

Ruxolitinib trial for Essential Thrombocythemia now enrolling patients

MPN News | November 13, 2017

Focus is on Hydroxyurea resistant/ intolerant ET

Read More

Patient Power webinar features PV patient discussing myMPN

MPN News | November 14, 2017

Dr. Srdan Verstovsek and MPNRF's Lindsey Whyte discuss new tool for patients

Read More

MPNRF Pursues Bold New Initiative: The Progression Marker Project

MPN News | 11/13/2017

MPNRF is launching a much needed initiative that could unlock answers about the rare blood cancer myeloproliferative neoplasms and identify new therapeutic targets.

Read More

NCCN develops patient-friendly MPN guidelines

MPN News | October 19, 2017

NCCN Guidelines for Patients are written in plain language and include patient-friendly tools.

Read More

Check our News - Archive for older news.

Get updates on MPN patients and research breakthroughs.

What are the latest developments in MPN Research?